Clover Health Investments, Corp. (NASDAQ:CLOV) Shares Purchased by Virtu Financial LLC

Virtu Financial LLC raised its stake in Clover Health Investments, Corp. (NASDAQ:CLOV) by 344.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 58,518 shares of the company’s stock after purchasing an additional 45,354 shares during the quarter. Virtu Financial LLC’s holdings in Clover Health Investments were worth $165,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Geode Capital Management LLC lifted its position in Clover Health Investments by 21.9% during the 3rd quarter. Geode Capital Management LLC now owns 4,828,701 shares of the company’s stock worth $13,622,000 after acquiring an additional 868,501 shares in the last quarter. State Street Corp raised its stake in shares of Clover Health Investments by 65.0% during the third quarter. State Street Corp now owns 2,189,380 shares of the company’s stock valued at $6,174,000 after purchasing an additional 862,621 shares during the period. XTX Topco Ltd acquired a new position in shares of Clover Health Investments during the second quarter worth $932,000. Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of Clover Health Investments by 75.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,128,171 shares of the company’s stock valued at $3,181,000 after purchasing an additional 485,987 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Clover Health Investments during the 3rd quarter valued at $1,228,000. Institutional investors and hedge funds own 19.77% of the company’s stock.

Clover Health Investments Price Performance

CLOV opened at $3.15 on Thursday. The stock has a market capitalization of $1.58 billion, a PE ratio of -15.75 and a beta of 1.94. Clover Health Investments, Corp. has a 12-month low of $0.61 and a 12-month high of $4.71. The firm’s fifty day moving average price is $3.61 and its 200 day moving average price is $2.65.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.03) by $0.01. The business had revenue of $330.99 million for the quarter, compared to analysts’ expectations of $347.60 million. Clover Health Investments had a negative net margin of 5.92% and a negative return on equity of 25.46%. During the same quarter last year, the company posted ($0.09) earnings per share. On average, equities research analysts forecast that Clover Health Investments, Corp. will post -0.12 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

CLOV has been the subject of a number of analyst reports. UBS Group began coverage on shares of Clover Health Investments in a research report on Monday, October 7th. They issued a “neutral” rating and a $4.00 price objective for the company. Craig Hallum initiated coverage on Clover Health Investments in a research note on Tuesday. They set a “buy” rating and a $6.00 price objective for the company.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.